GSK239512 DDI Study

NCT01802931 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: GSK239512
DRUG: ketoconazole

Sponsor

GlaxoSmithKline